Literature DB >> 23579341

Insights into congenital stationary night blindness based on the structure of G90D rhodopsin.

Ankita Singhal1, Martin K Ostermaier, Sergey A Vishnivetskiy, Valérie Panneels, Kristoff T Homan, John J G Tesmer, Dmitry Veprintsev, Xavier Deupi, Vsevolod V Gurevich, Gebhard F X Schertler, Joerg Standfuss.   

Abstract

We present active-state structures of the G protein-coupled receptor (GPCRs) rhodopsin carrying the disease-causing mutation G90D. Mutations of G90 cause either retinitis pigmentosa (RP) or congenital stationary night blindness (CSNB), a milder, non-progressive form of RP. Our analysis shows that the CSNB-causing G90D mutation introduces a salt bridge with K296. The mutant thus interferes with the E113Q-K296 activation switch and the covalent binding of the inverse agonist 11-cis-retinal, two interactions that are crucial for the deactivation of rhodopsin. Other mutations, including G90V causing RP, cannot promote similar interactions. We discuss our findings in context of a model in which CSNB is caused by constitutive activation of the visual signalling cascade.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23579341      PMCID: PMC3674435          DOI: 10.1038/embor.2013.44

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  35 in total

1.  Role of noncovalent binding of 11-cis-retinal to opsin in dark adaptation of rod and cone photoreceptors.

Authors:  V J Kefalov; R K Crouch; M C Cornwall
Journal:  Neuron       Date:  2001-03       Impact factor: 17.173

2.  Effect of channel mutations on the uptake and release of the retinal ligand in opsin.

Authors:  Ronny Piechnick; Eglof Ritter; Peter W Hildebrand; Oliver P Ernst; Patrick Scheerer; Klaus Peter Hofmann; Martin Heck
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

3.  Molecular mechanisms of disease for mutations at Gly-90 in rhodopsin.

Authors:  Darwin Toledo; Eva Ramon; Mònica Aguilà; Arnau Cordomí; Juan J Pérez; Hugo F Mendes; Michael E Cheetham; Pere Garriga
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

4.  Biased signaling pathways in β2-adrenergic receptor characterized by 19F-NMR.

Authors:  Jeffrey J Liu; Reto Horst; Vsevolod Katritch; Raymond C Stevens; Kurt Wüthrich
Journal:  Science       Date:  2012-01-19       Impact factor: 47.728

5.  Conformational dynamics of helix 8 in the GPCR rhodopsin controls arrestin activation in the desensitization process.

Authors:  Kristina Kirchberg; Tai-Yang Kim; Martina Möller; Darko Skegro; Gayathri Dasara Raju; Joachim Granzin; Georg Büldt; Ramona Schlesinger; Ulrike Alexiev
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-28       Impact factor: 11.205

6.  Constitutive "light" adaptation in rods from G90D rhodopsin: a mechanism for human congenital nightblindness without rod cell loss.

Authors:  P A Sieving; M L Fowler; R A Bush; S Machida; P D Calvert; D G Green; C L Makino; C L McHenry
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

7.  Slow binding of retinal to rhodopsin mutants G90D and T94D.

Authors:  Alecia K Gross; Guifu Xie; Daniel D Oprian
Journal:  Biochemistry       Date:  2003-02-25       Impact factor: 3.162

8.  Characterization of rhodopsin congenital night blindness mutant T94I.

Authors:  Alecia K Gross; Vikram R Rao; Daniel D Oprian
Journal:  Biochemistry       Date:  2003-02-25       Impact factor: 3.162

9.  Constitutive activation of opsin: interaction of mutants with rhodopsin kinase and arrestin.

Authors:  J Rim; D D Oprian
Journal:  Biochemistry       Date:  1995-09-19       Impact factor: 3.162

10.  Crystal structures of a stabilized β1-adrenoceptor bound to the biased agonists bucindolol and carvedilol.

Authors:  Tony Warne; Patricia C Edwards; Andrew G W Leslie; Christopher G Tate
Journal:  Structure       Date:  2012-05-09       Impact factor: 5.006

View more
  37 in total

Review 1.  Extensive shape shifting underlies functional versatility of arrestins.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Curr Opin Cell Biol       Date:  2013-11-16       Impact factor: 8.382

Review 2.  GPCRs and Signal Transducers: Interaction Stoichiometry.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Trends Pharmacol Sci       Date:  2018-05-05       Impact factor: 14.819

Review 3.  Microbial and animal rhodopsins: structures, functions, and molecular mechanisms.

Authors:  Oliver P Ernst; David T Lodowski; Marcus Elstner; Peter Hegemann; Leonid S Brown; Hideki Kandori
Journal:  Chem Rev       Date:  2013-12-23       Impact factor: 60.622

4.  G protein-coupled receptors: the evolution of structural insight.

Authors:  Samantha B Gacasan; Daniel L Baker; Abby L Parrill
Journal:  AIMS Biophys       Date:  2017-08-21

5.  Rapid degeneration of rod photoreceptors expressing self-association-deficient arrestin-1 mutant.

Authors:  Xiufeng Song; Jungwon Seo; Faiza Baameur; Sergey A Vishnivetskiy; Qiuyan Chen; Seunghyi Kook; Miyeon Kim; Evan K Brooks; Christian Altenbach; Yuan Hong; Susan M Hanson; Maria C Palazzo; Jeannie Chen; Wayne L Hubbell; Eugenia V Gurevich; Vsevolod V Gurevich
Journal:  Cell Signal       Date:  2013-09-03       Impact factor: 4.315

Review 6.  Constitutively active rhodopsin and retinal disease.

Authors:  Paul Shin-Hyun Park
Journal:  Adv Pharmacol       Date:  2014

7.  Enhanced phosphorylation-independent arrestins and gene therapy.

Authors:  Vsevolod V Gurevich; Xiufeng Song; Sergey A Vishnivetskiy; Eugenia V Gurevich
Journal:  Handb Exp Pharmacol       Date:  2014

8.  Arrestins in apoptosis.

Authors:  Seunghyi Kook; Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Handb Exp Pharmacol       Date:  2014

9.  Self-association of arrestin family members.

Authors:  Qiuyan Chen; Ya Zhuo; Miyeon Kim; Susan M Hanson; Derek J Francis; Sergey A Vishnivetskiy; Christian Altenbach; Candice S Klug; Wayne L Hubbell; Vsevolod V Gurevich
Journal:  Handb Exp Pharmacol       Date:  2014

10.  Structural role of the T94I rhodopsin mutation in congenital stationary night blindness.

Authors:  Ankita Singhal; Ying Guo; Milos Matkovic; Gebhard Schertler; Xavier Deupi; Elsa Cy Yan; Joerg Standfuss
Journal:  EMBO Rep       Date:  2016-07-25       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.